180 related articles for article (PubMed ID: 7543432)
1. The significance of immunoglobulin M antibody response to hepatitis C virus core protein in patients with chronic hepatitis C.
Yuki N; Hayashi N; Ohkawa K; Hagiwara H; Oshita M; Katayama K; Sasaki Y; Kasahara A; Fusamoto H; Kamada T
Hepatology; 1995 Aug; 22(2):402-6. PubMed ID: 7543432
[TBL] [Abstract][Full Text] [Related]
2. Significance of serum immunoglobulin M to hepatitis C virus core in patients with chronic hepatitis C.
Tran A; Yang G; Dreyfus G; Rouquié P; Durant J; Rampal A; Rampal P; Benzaken S
Am J Gastroenterol; 1997 Oct; 92(10):1835-8. PubMed ID: 9382047
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin M antibody to hepatitis C virus core antigen: correlations with viral replication, histological activity, and liver disease outcome.
Quiroga JA; van Binsbergen J; Wang CY; Pardo M; Navas S; Trines C; Herrero M; Carreño V
Hepatology; 1995 Dec; 22(6):1635-40. PubMed ID: 7489967
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection.
Yuki N; Hayashi N; Kasahara A; Hagiwara H; Mita E; Ohkawa K; Katayama K; Fusamoto H; Kamada T
Hepatology; 1996 May; 23(5):947-52. PubMed ID: 8621173
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy.
Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
Hepatology; 1993 Jun; 17(6):960-5. PubMed ID: 7685734
[TBL] [Abstract][Full Text] [Related]
6. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
[TBL] [Abstract][Full Text] [Related]
7. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
Pawlotsky JM; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy CJ; Dhumeaux D
J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus recurrence after liver transplantation: relationship to anti-HCV core IgM, genotype, and level of viremia.
Crespo J; Carte B; Lozano JL; Casafont F; Rivero M; de la Cruz F; Pons-Romero F
Am J Gastroenterol; 1997 Sep; 92(9):1458-62. PubMed ID: 9317062
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus replication and antibody responses toward specific hepatitis C virus proteins.
Yuki N; Hayashi N; Kasahara A; Hagiwara H; Ohkawa K; Fusamoto H; Kamada T
Hepatology; 1994 Jun; 19(6):1360-5. PubMed ID: 7514560
[TBL] [Abstract][Full Text] [Related]
10. Identification of serologically silent occult hepatitis C virus infection by detecting immunoglobulin G antibody to a dominant HCV core peptide epitope.
Quiroga JA; Castillo I; Llorente S; Bartolomé J; Barril G; Carreño V
J Hepatol; 2009 Feb; 50(2):256-63. PubMed ID: 19070391
[TBL] [Abstract][Full Text] [Related]
11. IgG and IgM core antibodies and viral replication in hepatitis C virus carriers.
Yuki N; Hayashi N; Hagiwara H; Naito M; Ohkawa K; Katayama K; Kasahara A; Fusamoto H; Kamada T
J Hepatol; 1994 Jul; 21(1):110-4. PubMed ID: 7525692
[TBL] [Abstract][Full Text] [Related]
12. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections.
Ferrari C; Valli A; Galati L; Penna A; Scaccaglia P; Giuberti T; Schianchi C; Missale G; Marin MG; Fiaccadori F
Hepatology; 1994 Feb; 19(2):286-95. PubMed ID: 8294086
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA.
Tanaka E; Ohue C; Aoyagi K; Yamaguchi K; Yagi S; Kiyosawa K; Alter HJ
Hepatology; 2000 Aug; 32(2):388-93. PubMed ID: 10915747
[TBL] [Abstract][Full Text] [Related]
14. Anti-hepatitis C virus immunoglobulin M antibody in patients with chronic hepatitis type C.
Kikuchi T; Onji M; Michitaka K; Ohta Y
Hepatogastroenterology; 1992 Dec; 39(6):525-8. PubMed ID: 1336473
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of antibody to Y19 protein in nonA and nonB chronic liver disease].
Sakashita H
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):159-72. PubMed ID: 7686128
[TBL] [Abstract][Full Text] [Related]
16. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.
Pawlotsky JM; Darthuy F; Rémiré J; Pellet C; Udin L; Stuyver L; Roudot-Thoraval F; Duvoux C; Douvin C; Mallat A
J Med Virol; 1995 Nov; 47(3):285-91. PubMed ID: 8551282
[TBL] [Abstract][Full Text] [Related]
17. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
[TBL] [Abstract][Full Text] [Related]
18. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
Cerino A; Bissolati M; Cividini A; Nicosia A; Esumi M; Hayashi N; Mizuno K; Slobbe R; Oudshoorn P; Silini E; Asti M; Mondelli MU
J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
[TBL] [Abstract][Full Text] [Related]
19. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reverse-transcription polymerase chain reaction.
Lau GK; Davis GL; Wu SP; Gish RG; Balart LA; Lau JY
Hepatology; 1996 Jun; 23(6):1318-23. PubMed ID: 8675145
[TBL] [Abstract][Full Text] [Related]
20. Clinical importance of assessment of anti-HCV IgM antibodies in chronic hepatitis C.
Stránský J; Honzáková E; Vandasová J; Horejsová M; Kyncl J; Nĕmecek V; Horák J
Acta Virol; 1996 Apr; 40(2):61-5. PubMed ID: 8886113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
